AU2001270963A1 - Transdermal drug delivery system - Google Patents

Transdermal drug delivery system

Info

Publication number: AU2001270963A1
Authority: AU; Australia
Prior art keywords: delivery system; drug delivery; transdermal drug; transdermal; drug
Prior art date: 2000-07-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001270963A

Inventor

Raphael Gorodischer

Amnon Sintov

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ben Gurion University of the Negev Research and Development Authority Ltd

Original Assignee

Ben Gurion University of the Negev Research and Development Authority Ltd

Ben Gurion University of the Negev BGU

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-27

Filing date

2001-07-10

Publication date

2002-02-13

2001-07-10 Application filed by Ben Gurion University of the Negev Research and Development Authority Ltd, Ben Gurion University of the Negev BGU filed Critical Ben Gurion University of the Negev Research and Development Authority Ltd

2002-02-13 Publication of AU2001270963A1 publication Critical patent/AU2001270963A1/en

Status Abandoned legal-status Critical Current

Links

238000013271 transdermal drug delivery Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AU2001270963A 2000-07-27 2001-07-10 Transdermal drug delivery system Abandoned AU2001270963A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL137559		2000-07-27
IL137559A IL137559A (en)	2000-07-27	2000-07-27	Transdermal drug delivery system
PCT/IL2001/000630 WO2002009763A2 (en)	2000-07-27	2001-07-10	Transdermal drug delivery system

Publications (1)

Publication Number	Publication Date
AU2001270963A1 true AU2001270963A1 (en)	2002-02-13

Family

ID=11074457

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001270963A Abandoned AU2001270963A1 (en)	2000-07-27	2001-07-10	Transdermal drug delivery system

Country Status (6)

Country	Link
US (1)	US20030170296A1 (en)
EP (1)	EP1307231A2 (en)
AU (1)	AU2001270963A1 (en)
CA (1)	CA2417275A1 (en)
IL (1)	IL137559A (en)
WO (1)	WO2002009763A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050226910A1 (en) *	2002-06-20	2005-10-13	Amnon Sintov	Transdermal drug delivery system
ES2535045T3 (en)	2003-04-10	2015-05-04	Vanderbilt Royalty Sub L.P.	Uses and compositions for capsaicin administration
US8157788B2 (en) *	2003-11-06	2012-04-17	Paolo L. Manfredi	Multi-site drug delivery platform
JP2007538010A (en) *	2004-05-07	2007-12-27	ファイトトックスリミテッド	Transdermal administration of phycotoxin
US8252319B2 (en)	2004-10-21	2012-08-28	Durect Corporation	Transdermal delivery system for sufentanil
SI1814531T1 (en)	2004-10-21	2010-10-29	Durect Corp	Transdermal delivery systems
DE102005021806A1 (en) *	2005-05-04	2006-11-16	Lancaster Group Gmbh	Use of radical-scavenging substances for the treatment of conditions with increased skin temperature, in particular for antipyretic treatment
US20070065494A1 (en) *	2005-08-03	2007-03-22	Watson Laboratories, Inc.	Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
EP2155175B1 (en) *	2007-06-08	2014-03-12	Samyang Biopharmaceuticals Corporation	Matrix-type transdermal drug delivery system and preparation method thereof
US20090130048A1 (en) *	2007-11-19	2009-05-21	Oronsky Bryan Todd	Topical Composition for Treating Pain
US8784872B2 (en)	2007-11-19	2014-07-22	Comgenrx, Inc.	Formulation for decreasing tobacco, alcohol, drug or food consumption
WO2009158667A2 (en) *	2008-06-27	2009-12-30	Comgenrx, Inc.	Povidone compositions for wound healing
CN102256602A (en) *	2008-10-21	2011-11-23	诺沃德米克斯国际有限公司	Compositions for treating epithelial tissue
IT1397246B1 (en) *	2009-05-14	2013-01-04	Fidia Farmaceutici	NEW MEDICATIONS FOR TOPIC USE BASED HYALURONIC ACID SULFATED AS AN ACTIVATING OR INHABITING CITHOCINIC ACTIVITY
EP4522120A1 (en)	2022-06-03	2025-03-19	Dow Global Technologies LLC	Formulation for transdermal delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH655656B (en) *	1982-10-07	1986-05-15
US4908389A (en) *	1986-08-27	1990-03-13	Warner-Lambert Company	Penetration enhancement system
ATE164080T1 (en) *	1990-05-10	1998-04-15	Bechgaard Int Res	PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLES AND N-ETHYLENE GLYCOLS
US5192802A (en) *	1991-09-25	1993-03-09	Mcneil-Ppc, Inc.	Bioadhesive pharmaceutical carrier
US5985860A (en) *	1992-06-03	1999-11-16	Toppo; Frank	System for transdermal delivery of pain relieving substances
FI950345A7 (en) *	1992-07-27	1995-01-26	Procter & Gamble	Laminated dual-textured nursing pads
IL118235A0 (en) *	1996-05-13	1996-09-12	Univ Ben Gurion	Composition and method for forming biodegradable implants in situ and uses of these implants
DE69739583D1 (en) *	1996-11-14	2009-10-29	Lipomedica Ehf	TOPICAL COMPOSITIONS CONTAIN AS A THERAPEUTICALLY ACTIVE AGENT A MONOGLYCERIDE FOR THE TREATMENT OF SLEW-TONE INFECTIONS
IT1291362B1 (en) *	1997-05-13	1999-01-07	Vectorpharma Int	BIPHASIC MULTICOMPONENT PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTANCES SUITABLE TO MODIFY THE PARTITION OF THE ACTIVE SUBSTANCES
US6348212B2 (en) *	1999-05-18	2002-02-19	Lectec Corporation	Treating traumatic burns or blisters of the skin
US6645520B2 (en) *	1999-12-16	2003-11-11	Dermatrends, Inc.	Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US20050226910A1 (en) *	2002-06-20	2005-10-13	Amnon Sintov	Transdermal drug delivery system

2000
- 2000-07-27 IL IL137559A patent/IL137559A/en not_active IP Right Cessation
2001
- 2001-07-10 WO PCT/IL2001/000630 patent/WO2002009763A2/en not_active Ceased
- 2001-07-10 AU AU2001270963A patent/AU2001270963A1/en not_active Abandoned
- 2001-07-10 CA CA002417275A patent/CA2417275A1/en not_active Abandoned
- 2001-07-10 EP EP01949852A patent/EP1307231A2/en not_active Withdrawn
- 2001-07-10 US US10/343,008 patent/US20030170296A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002009763A2 (en)	2002-02-07
WO2002009763A3 (en)	2002-04-18
IL137559A0 (en)	2001-07-24
US20030170296A1 (en)	2003-09-11
IL137559A (en)	2006-12-31
EP1307231A2 (en)	2003-05-07
CA2417275A1 (en)	2002-02-07

Publication	Publication Date	Title
AU2001264887A1 (en)	2001-12-03	Drug delivery device
AU2123200A (en)	2000-08-18	Drug delivery device
AU4985600A (en)	2000-11-21	Drug delivery device
AU2001235009A1 (en)	2001-11-01	Drug delivery apparatus
AU2001288388A1 (en)	2002-03-04	Substance delivery system
AU2002353444A1 (en)	2003-05-19	Integrated transdermal drug delivery system
AU4947100A (en)	2000-12-28	Drug delivery device
AU2001238386A1 (en)	2002-04-22	Medication delivery devices
AU2002343555A1 (en)	2003-05-26	Eutectic-based self-nanoemulsified drug delivery system
AU2001283359A1 (en)	2002-02-25	Drug release (delivery system)
AU2001283357A1 (en)	2002-02-25	Drug delivery system with bilayer electrodes
AUPR573001A0 (en)	2001-07-12	Lymphatic drug delivery system
AU2002210463A1 (en)	2002-05-30	Transdermal therapeutic system
AU2001275286A1 (en)	2001-12-17	Transdermal delivery
AU2001270963A1 (en)	2002-02-13	Transdermal drug delivery system
AU3837999A (en)	1999-11-29	Drug delivery device
AU2003212962A1 (en)	2003-09-02	Transdermal drug delivery systems
AU2001243515A1 (en)	2001-09-17	Combination drug therapy
AU2003241134A1 (en)	2004-01-06	Transdermal drug delivery system
AU2002222138A1 (en)	2002-06-18	Drug delivery system
AU2001244854A1 (en)	2001-10-03	Local drug delivery
AU2002210580A1 (en)	2002-04-29	Drug delivery system
IL149115A0 (en)	2002-11-10	Transdermal drug delivery devices
AUPR146700A0 (en)	2000-12-07	Drug delivery system
IL150334A0 (en)	2002-12-01	Transdermal drug delivery system